Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Abera Bioscience AB

Closing information (x1000 DKK)

Closing information 2024/12 (consolidated) 2023/12 2022/12
Turnover 0 More Arrow 1,777 Less Arrow 0
Financial expenses 1 Less Arrow 0 Equal arrow 0
Earnings before taxes -714 Less Arrow -11,228 Less Arrow -12,950
EBITDA -688 Less Arrow -11,283 Less Arrow -12,959
Total assets 8,835 Less Arrow 6,280 More Arrow 13,080
Current assets 6,915 Less Arrow 4,996 More Arrow 11,818
Current liabilities 3,213 Less Arrow 2,480 Less Arrow 1,868
Equity capital 5,622 Less Arrow 3,800 More Arrow 11,212
- share capital 798 Less Arrow 777 Less Arrow 690
Employees (average) 5 More Arrow 6 Equal arrow 6

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 2022/12
Solvency 63.6% Less Arrow 60.5% More Arrow 85.7%
Turnover per employee 0 More Arrow 296 Less Arrow 0
Profit as a percentage of turnover -631.9%
Return on assets (ROA) -8.1% Less Arrow -178.8% More Arrow -99.0%
Current ratio 215.2% Less Arrow 201.5% More Arrow 632.7%
Return on equity (ROE) -12.7% Less Arrow -295.5% More Arrow -115.5%
Change turnover
Change turnover % -100%
Chg. No. of employees
Chg. No. of employees % 0% More Arrow 20%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.